Nightcap: After slashing delivery and revenue estimates, Nikola keeps rolling
Nightly recap of the day's SPAC highlights (August 3, 2021)
Good evening,
Thanks for reading the “Nightcap”, a nightly recap of the highlights in the SPAC world. You can always discover and track all of the SPACs at spactrack.net.
The Stats:
If you find that this newsletter keeps you informed of all things SPAC, please consider sharing it with a friend or colleague and suggest they subscribe!
The Deals:
None today.
Deal News:
1) Hydrow in Talks to Go Public in Sandbridge X2 SPAC Deal (Bloomberg— behind paywall)
Hydrow, a maker of rowing machines, is in talks to go public through a merger with Sandbridge X2 Corp. (SBII: $9.76), according to people with knowledge of the matter.
The companies are in discussions about a transaction that values the combined entity at more than $1 billion, some of the people said. Sandbridge X2 is in talks with prospective investors about raising a private investment in public equity, one of the people added. Terms aren’t finalized and it’s possible talks could fall apart.
Hydrow and Sandbridge representatives declined to comment.
Cambridge, Massachusetts-based Hydrow, led by Chief Executive Officer Bruce Smith, had been exploring options such as an initial public offering or merging with a special purpose acquisition company, Bloomberg News reported in June. The company, which offers live and on-demand workouts -- also sells heart-rate monitors, headphones, yoga blocks, resistance bands and foam rollers, its website shows.
Hydrow competes in the at-home fitness market against companies including industry behemoth Peloton Interactive Inc. Its investors include LVMH-backed private equity firm L Catterton; Rx3 Ventures, co-founded by Green Bay Packers quarterback Aaron Rodgers; Sandbridge Capital; Activant Capital and Winklevoss Capital Management, PitchBook data show.
2) Traveloka in Talks to Raise Up to $400 Million for SPAC Deal (Bloomberg— behind paywall)
Indonesia’s Traveloka is in talks with potential investors to raise as much as $400 million as part of its plan to go public through merging with a blank-check company backed by billionaires Richard Li and Peter Thiel, according to people familiar with the matter.
The fundraising, a so-called private investment in public equity, would be part of a deal to merge the Jakarta-based online travel startup with Bridgetown Holdings Ltd. (BTWN: $9.83) as soon as this year, said the people, who asked not to be identified because the matter is private. The merger is set to value the combined entity at about $5 billion, the people said.
The PIPE amount discussed is about $200 million to $400 million and could still change, the people said. A representative for Traveloka declined to comment.
Traveloka is seeking funds for growth as its expands its geographic reach and the range of services it offers. A successful merger with Bridgetown would make Traveloka one of the first Southeast Asian unicorns to go public through a special purpose acquisition company, or SPAC.
3) ICYMI Yesterday:
SPAC-on-SPAC Deal Falls Apart, and So Does Immunovant’s Stock (Bloomberg— behind paywall)
A private drugmaker aborted plans to buy back its own SPAC at a hefty premium, sending shares of Immunovant Inc. (IMVT: $7.01) plunging to an all-time low.
The withdrawal by Roivant Sciences Ltd. unwinds part of its plan to go public by selling itself to a special-purpose acquisition company, and then using the proceeds to reacquire full ownership of Immunovant, which it merged into another SPAC in 2019. Immunovant’s stock, which topped $53 last year, closed 26% lower.
Instead, Roivant said in a statement Monday, it bought roughly 17 million shares for about $200 million that will fund continued development of Immunovant’s treatment for autoimmune diseases. That pushes Roivant’s stake to 63.8% from 57.5%. It picked up those shares at $11.75 each, which Roivant said was a 15% premium to the recent average price. Roivant still plans to proceed with its own SPAC merger.
“Roivant and Immunovant explored a range of possible transactions over the past few months, including a potential acquisition by Roivant of the minority interest in Immunovant, and ultimately agreed on this significant investment,” Matt Gline, Roivant’s chief executive officer, said in the statement.
…
Roivant’s original plan was the first known instance of a SPAC-on-SPAC deal, and it raised eyebrows earlier this year after it was outlined in filings. In a circular scenario, Roivant wanted to merge with SPAC Montes Archimedes Acquisition Corp. (MAAC: $9.90), after which it planned to re-acquire Immunovant at a substantial premium that Robert W. Baird & Co. estimated could amount to $1.1 billion.
Other News:
Nikola cuts delivery outlook for its electric semi trucks (TechCrunch)
Nikola (NKLA: $10.21), the electric truck startup that went public via a SPAC merger, warned Tuesday that supply chain constraints are causing numerous delays forcing it to slash its vehicle delivery projections in half.
The company, which is still in pre-production, said in its second-quarter earnings call that its plans to produce 50 to 100 electric semi trucks in this year have been lowered to 25 to 50 units. The less than rosy projections continued on the revenue front.
The company cut its revenue forecast for the year to $0 to $7.5 million. It was previously $15 million to $30 million.
Nikola reported a net loss of $143 million in the second quarter, up from a $115.7 million loss in the same period last year. Its adjusted loss was 20 cents per share, which is actually better than analysts expected. The company’s cash balance at the end of the quarter was $632.6 million.
While the company focused its earnings call on its progress toward producing electric trucks — which included testing pre-production vehicles and completing 0.5 Phase of its factory in Arizona — the market was more interested in its lowered outlook and the lingering effects from its founder Trevor Milton being charged with securities fraud. Among the company’s updates is that it has built 14 pre-production vehicles, five alpha and nine beta prototypes.
Shares of Nikola were down 7.47% in midday trading.
Quick News Corner:
Gores Holdings V, Inc (GRSV: $10.50) & Ardagh Metal Packaging’s merger has been approved by shareholders
IPOs to Begin Trading Tomorrow*:
1) AMCI Acquisition Corp. II (AMCI-U)
$150M, 1/2 warrant
Focus: Sustainability, decarbonization, and energy transition
*Priced at the time of this writing
New S-1s:
1) Emerging Markets Horizon Corp. (HORI)
$250M, 1/3 warrant
Focus: Tech and Consumer in CEE, Russia, or the CIS
Upcoming Dates:
This Week’s Announced Shareholder Meetings, Unit Splits, Warrant Redemptions
Wednesday, August 4
Unit Split: CleanTech Acquisition Corp. (CLAQ-U: $10.17)
Thursday, August 5
Merger Meetings:
Peridot Acquisition Corp. (PDAC: $9.55) & Li-Cycle
Reinvent Technology Partners (RTP: $9.94) & Joby Aviation
Friday, August 6
Merger Meeting: SC Health Corp (SCPE: $9.79) & Rockley Photonics
If you haven’t subscribed to this free nightly newsletter, you can do so below.
Thanks for reading,